Evidence of effectiveness of herbal medicinal products in the treatment of arthritis - Part 1: Osteoarthritis

Phytotherapy Research

Volumn 23, Issue 11, 2009, Pages 1497-1515

  Cameron, Melainie ^a,b   Gagnier, Joel J ^c   Little, Christine V ^d   Parsons, Tessa J ^e   Blümle, Anette ^f   Chrubasik, Sigrun ^g  

^a VICTORIA UNIVERSITY   (Australia)

^b AUSTRALIAN CATHOLIC UNIVERSITY   (Australia)

^c BMJ Group   (Canada)

^d BOURNEMOUTH UNIVERSITY   (United Kingdom)

^e UNIVERSITY COLLEGE LONDON   (United Kingdom)

^f UNIVERSITY OF FREIBURG   (Germany)

^g UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Clinical trials; Cochrane review; Effectiveness; Herbal medicine; Osteoarthritis

Indexed keywords

ARNICA MONTANA EXTRACT; BOSWELLIA EXTRACT; BOSWELLIA SERRATA EXTRACT; CAPSAICIN; COMFREY EXTRACT; DICLOFENAC; DUHUO JISHENG WAN; GINGER EXTRACT; GLYCERYL TRINITRATE; HARPAGOPHYTUM PROCUMBENS EXTRACT; HERBACEOUS AGENT; IBUPROFEN; NONSTEROID ANTIINFLAMMATORY AGENT; PHYTODOLOR N; PIASCLEDINE; PIROXICAM; PLACEBO; REUMALEX; ROSAE CANINAE PSUEDOFRUCTUS CUM FRUCTIBUS; SALIX EXTRACT; SKI 306X; TIPI TEA; UNCARIA GUIANENSIS EXTRACT; UNCLASSIFIED DRUG; URTICA DIOICA EXTRACT;

BARK; BOSWELLIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DATA BASE; DRUG EFFICACY; DRUG WITHDRAWAL; HUMAN; OSTEOARTHRITIS; PAIN; PLANT LEAF; PLANT SEED; RANDOMIZED CONTROLLED TRIAL; REVIEW; UNCARIA; UNSPECIFIED SIDE EFFECT;

HUMANS; OSTEOARTHRITIS; PHYTOTHERAPY; PLANTS, MEDICINAL; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

GLYCINE MAX; PERSEA AMERICANA; SALIX ARBUSCULOIDES;

EID: 70350451836     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.3007     Document Type: Review

References (178)

1. Abdelouahab N, Heard C. 2008. Effect of the major glycosides of Harpagophytum procumbens (Devil's Claw) on epidermal cyclooxygenase-2 (COX-2) in vitro. J Nat Prod 71: 746-749. (Pubitemid 351841415)
2. Aguilar JL, Rojas P, Marcelo A, Plaza A, Bauer R, Reininger E, Klaas CA, Merfort I. 2002. Anti-inflammatory activity of two different extracts of Uncaria tomentosa (Rubiaceae). J Ethnopharmacol 81: 271-276. (Pubitemid 34628513)
3. Allen-Hall L, Cano P, Arnason JT, Rojas R, Lock O, Lafrenie RM. 2007. Treatment of THP-1 cells with Uncaria tomentosa extracts differentially regulates the expression if IL-1β and TNF-α. J Ethnopharmacol 109: 312-317. (Pubitemid 46001532)
4. Altinel L, Saritas ZK, Kose KC, Pamuk K, Aksoy Y, Serteser M. 2007. Treatment with unsaponifiable extracts of avocado and soybean increases TGF-beta1 and TGF-beta2 levels in canine joint fluid. Tohoku J Exp Med 211: 181-186. (Pubitemid 46268076)
5. Altman R, Asch E, Bloch D, Bole G, Borenstein D, Brandt K, Christy W, Cooke TD, Greenwald R, Hochberg M, Howell D, Kaplan D, Koopman W, Longley III S, Mankin H, McShane DJ, Medsger Jr. T, Meenan R, Mikkelsen W, Moskowitz R, Murphy W, Rothschild B, Segal M, Sokoloff L, Wolfe F. 1986. The American College of Rheumatology crtieria for the classifi cation and reporting of osteoarthritis of the knee. Arthritis Rheum 29: 1039-1049.
6. Altman R, Alarcon G, Appelrouth D, Bloch D, Borenstein D, Brandt K. 1990. The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hand. Arthritis Rheum 33: 1601-1610. (Pubitemid 20273289)
7. Altman R, Alarcon G, Appelrouth D, Bloch D, Borenstein D, Brandt K, Brown C, Cooke TD, Daniel W, Feldman D, Greenwald R, Hochberg M, Howell D, Ike R, Kapila P, Kaplan D, Koopman W, Marino C, McDonald E, McShane DJ, Medsger T, Michel B, Murphy WA, Osial T, Ramsey-Goldman R, Rothschild B, Wolfe F. 1991. The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hip. Arthritis Rheum 134: 505-514.
8. Altman R, Aven A, Holmburg E, Pfeifer LM. 1994. Capsaicin cream 0.025% as monotherapy for osteoarthritis: A double-blind study. Sem Arthritis Rheumatism 23 (Supp 3): 25-32. (Pubitemid 24209632)
9. Altman RD, Hochberg MC, Moskowitz RW, Schnitzer TJ. 2000. Recommendations for the medical management of osteoarthritis of the hip and knee. Arthritis Rheum 43:1905-1915. (Pubitemid 30953253)
10. Altman RD, Marcussen KC. 2001. Effects of a ginger extract on knee pain in patients with osteoarthritis. Arthritis Rheumatism 44: 2531-2538.
11. Altmann A, Poeckel D, Fischer L, Schubert-Zsilavecz M, Steinhilber D, Werz, O. 2004. Coupling of boswellic acid-induced Ca2+ mobilisation and MAPK activation to lipid metabolism and peroxide formation in human leucocytes. B J Pharmacol 141: 223-232. (Pubitemid 38250892)
12. Ammon HP, Mack T, Singh GB, Safayhi H. 1991. Inhibition of leukotriene B4 formation in rat peritoneal neutrophils by an ethanolic extract of the gum resin exudate of Boswellia serrata. Planta Med 57: 203-207.
13. Ammon HP, Safayhi H, Mack T, Sabieraj J. 1993. Mechanism of antiinflammatory actions of curcumine and boswellic acids. J Ethnopharmacol 38: 113-119. (Pubitemid 23136055)
14. Andersen MB, Stoové MA. 1998. The sanctity of p > .05 obfuscates good stuff: A comment on Kerr and Goss. J Appl Sport Psychol 10:168-173.
15. Andriamanalijaona R, Benateau H, Barre PE, Boumediene K, Labbe D, Compere JF, Pujol JP. 2006. Effect of interleukin-1beta on transforming growth factor-beta and bone morphogenetic protein-2 expression in human periodontal ligament and alveolar bone cells in culture: modulation by avocado and soybean unsaponifiables. J Peridontology 77: 1156-1166. (Pubitemid 44725021)
16. Anonymous. 2003. Harpagophyti redix. In ESCOP Monographs. Thieme Press Stuttgart: New York; 233-240
17. Appelboom T, Schuermans J, Verbruggen G, Henrotin Y, Reginster JY. 2001. Symptoms modifying effect of avocado/ soyabean unsaponifiables (ASU) in knee osteoarthritis: A double-blind, prospective, placebo-controlled study. Scand J Rheumatology 30: 242-247. (Pubitemid 32762863)
18. Asnani V, Verma RJ. 2007. Antioxidative effect of rhizome of Zinziber officinale on paraben induced lipid peroxidation: an in vitro study. Acta Pol Pharm 64: 35-37. (Pubitemid 351360439)
19. Astin JA. 1998. Why patients use alternative medicine: Results of a national study. JAMA 279: 1548-1553. (Pubitemid 28233010)
20. Atherton DJ. 1994. Towards the safer use of traditional remedies. Br Med J 308: 673-674.
21. Au RY, Al-Talib TK, Au AY, Phan PV, Frondoza CG. 2007. Avocado soybean unsaponifiables (ASU) suppress TNF-alpha, IL-1beta, COX-2, iNOS gene expression, and prostaglandin E(2) and nitric oxide production in articular chondrocytes and monocyte/macrophages. Osteoarthritis Cartilage 15: 1249-1255.
22. Badria FA, El-Farahaty T, Shabana AA, Hawas SA, El-Batoty MF. 2002. Boswellia-curcumin preparation for treating knee osteoarthritis: A clinical evaluation. Alternat Complement Ther 8: 341-348. (Pubitemid 35477458)
23. Begg C, Cho M, Eastwood S, Horeton R, Moher D, Olkin I, Pitkin R, Rennie D, Schulz KF, Simel D, Stroup DF. 1996. Improving the quality of reporting of randomized controlled trials. The CONSORT Statement. J Am Med Ass 276: 637-639. (Pubitemid 26278070)
24. Bengmark S. 2006. Curcumin, an atoxic antioxidant and natural NFkappaB, cyclooxygenase-2, lipooxygenase, and inducible nitric oxide synthase inhibitor: a shield against acute and chronic diseases. J Parenter Enteral Nutr 30: 45-51. (Pubitemid 43102234)
25. Bernhardt M, Keimel A, Belucci G, Spasojevic P. 1991. Double-blind, randomized, comparative study of Phytodolor N and placebo as well as an open comparison with Felden 20 Tabs involving convalescent inpatients with arthrotic joint alterations. Unpublished Pharma Report [Steigrwald Pharmaceuticals, Germany].
26. Biegert C, Wagner I, Ludtke R, Kotter I, Lohmuller C, Gunaydin I, Taxis K, Heide L. 2004. Efficacy and safety of willow bark extract in the treatment of osteoarthritis and rheumatoid arthritis: Results of 2 randomized double-blind controlled trials. J Rheumatology 31: 2121-2130. (Pubitemid 39453229)
27. Biller A. 2002. Results of two randomized controlled studies and of a post-marketing surveillance study investigating a Devil's claw extract [Ergebnisse zweier randomisierter kontrollierter Studien und einer Anwendungsbeobachtung mit Teufelskrallenextrakt]. In Phylopharmaka VII, Schulz V, Rietbrock N, Roots I, Loew D (eds). Steinkopf-Verlag: Darmstadt; 81-92.
28. Bliddal H, Rosetzsky A, Schlichting P, Weidner MS, Andersen LA, Ibfelt HH, Christensen K, Jensen ON, Barslev J. 2000. A randomized, placebo-controlled, crossover study of ginger extracts and ibuprofen in osteoarthritis. Osteoarthritis Cartilage 8: 9-12. (Pubitemid 30032721)
29. Blotman F, Maheu E, Wulwik A, Caspard H, Lopez A. 1997. Efficacy and safety of avocado/soybean unsaponifiables in the treatment of symptomatic osteoarthritis of the knee and hip [Efficacite et tolerance des insaponifiables d'avocat/soja dans le traitement de la gonarthrose et de la coxarthrose symptomatiques]. Rev Rhumatisme 64: 825-834.
30. Boje K, Lechtenberg M, Nahrstedt A. 2003. New and known iridoid- and phenylethanoid glycosides from Harpagophytum procumbens and their in vitro inhibition of human leukocyte elastase. Planta Med 69: 820-825. (Pubitemid 37346569)
31. Bonaterra G, Kinscherf R, Kelber O, Weizer D, Metz J. 2007. Anti-inflammatory effects of Populus tremula, Fraxinus excelsior, Solidago virgaurea extracts and their combination Phytodolor® in human monocytes. Planta Med 73: 842.
32. Boullata JI, McDonnell PJ, Oliva CD. 2003. Anaphylactic reaction to a dietary supplement containing willow bark. Ann Pharmacother 37: 832-835.
33. Boumediene K, Felisaz N, Bogdanowicz P, Galera P, Guillou GB, Pujol JP. 1999. Avocado/soya unsaponifiables enhance the expression of transforming growth factor beta1 and beta2 in cultured articular chondrocytes. Arthritis Rheum 42: 148-156. (Pubitemid 29042581)
34. Buck SH, Burks TF. 1986. The neuropharmacology of capsaicin: Review of some recent observations. Pharmacology Rev 38: 179-226. (Pubitemid 16031645)
35. Cameron M. 2007. When research goes pear-shaped: Report and reflections on a failed study of exercize and manual therapies for rheumatoid arthritis. Complement. Health Practice Rev 12: 63-77.
36. Cao ZF, Chen ZG, Guo P, Zhang SM, Lian LX, Luo L, Hu WM. 1993. Scavenging effects of ginger on superoxide anion and hydroxyl radical. Zhongguo Zhong Yao Za Zhi 18: 750-751, 764.
37. Chainani-Wu N. 2003. Safety and anti-inflammatory activity of curcumin: a component of tumeric (Curcuma longa). J Alternat Complement Med 9: 161-168. (Pubitemid 36297021)
38. Chevrier MR, Ryan AE, Lee DY, Zhongze M, Wu-Yan Z, Via CS. 2005. Boswellia carterii extract inhibits TH1 cytokines and promotes TH2 cytokines in vitro. Clin Diagn Lab Immunol 12: 75-80.
39. Choi JH, Kim DY, Yoon JH, Youn HY, Yi JB, Rhee HI, Ryu KH, Jung K, Han CK, Kwak WJ, Cho YB. 2002. Effects of SKI 306X, a new herbal agent, on proteoglycan degradation in cartilage explant culture and collagenase-induced rabbit osteoarthritis model. Osteoarthritis Cartilage 10: 471-478. (Pubitemid 34679299)
40. Chrubasik S, Junck H, Breitschwerdt H, Conradt C, Zappe H. 1999. Effectiveness of Harpagophytum extract WS 1531 in the treatment of exacerbation of low back pain: A randomized, placebo-controlled, double-blind study. Eur J Anaesthesiol 16: 118-129. (Pubitemid 29123561)
41. Chrubasik S, Eizenberg E, Balan E, Weinberger T, Luzzati R, Conradt C. 2000. Treatment of low back pain exacerbations with willow bark extract: A randomized double-blind study. Am J Med 109: 9-14. (Pubitemid 30608731)
42. Chrubasik S, Thanner J, Künzel O, Conradt C, Black A, Pollak S. 2002a. Comparison of outcome measures during treatment with the proprietary Harpagophytum extract Doloteffin in patients with pain in the lower back, knee or hip. Phytomedicine 9: 181-194. (Pubitemid 34475549)
43. Chrubasik S, Fiebich B, Black A, Pollak S. 2002b. Treating low back pain with an extract of Harpagophytum that inhibits cytokine release. Eur J Anaesthesiol 19: 209.
44. Chrubasik JE, Lindhorst E, Neumann E, Gerlach U, Faller-Marquardt M, Torda T, Muller-Ladner U, Chrubasik S. 2006. Potential molecular basis of the chondroprotective effect of Harpagophytum procumbens. Phytomedicine 13: 598-600. (Pubitemid 44224051)
45. Chrubasik JE, Roufogalis BD, Chrubasik, S. 2007. Evidence of effectiveness of herbal anti-inflammatory drugs in the treatment of painful osteoarthritis including chronic low back pain. Phytotherapy Res 21: 675-683.
46. Chrubasik JE, Roufogalis BD, Wagner H, Chrubasik S. 2008. Systematic review on the safety of Harpagophytum preparations for osteoarthritic and low back pain. Phytotherapy Res 22: 149-152.
47. Daels-Rakotoarison DA, Gressier B, Trotin F, Brunet C, Luyckx M, Dine T, Bailleul F, Cazin M, Cazin JC. 2002. Effects of Rosa canina fruit extract on neutrophil respiratory burst. Phytother Res 16: 157-161. (Pubitemid 34297459)
48. Deal CL, Schnitzer TJ, Lipstein E, Seibold JR, Stevens RM, Levy MD, Albert D, Renold F. 1991. Treatment of arthritis with topical capsaicin: A double-blind trial. Clin Ther 13: 383-395.
49. Dedov VN, Roufogalis BD. 2000. Mitochondrial calcium accumulation following activation of vanilloid (VR1) receptors by capsaicin in dorsal root ganglion neurons. Neurosci 95: 183-188.
50. Dreizer R, Maheu E, Julien D. 1997. Proposal of equivalence scores for non-steroidal anti-inflammatory drugs and analgesics for arthritis [Abstract] [Proposition d'un score d'equivalence des anti-inflammatoires non steroidiens (AINS) et des antalgiques dans l'arthrose [Abstract]]. Rev Rhumatisme 51: 818.
51. El Haouari M, Bnouham M, Bendahou M, Aziz M, Ziyyat A, Legssyer A, MekhfiH. 2006. Inhibition of rat platelet aggregation by Urtica dioica leaves extracts. Phytotherapy Res 20: 568-572.
52. Ernst E. 1995. Bitter pills of nature: Safety issues in complementary medicine. Pain 60: 237-238.
53. Ernst E, Willoughby M, Weihmayr TH. 1995. Nine possible reasons for choosing complementary medicine. Perfusion 8: 356-358.
54. Ernst E. 1996. Plants as medicine: Possible benefits and potential risks. Br J Ther Rehab 3: 99-100.
55. Ernst E.1998. Over-the-counter complementary remedies used for arthritis. Pharmaceutical J 260: 30-831.
56. Ferraz MB, Pereira RB, Iwata NM, Atra E. 1991. Tipi. A popular analgesic tea: A double-blind crossover trial in osteoarthritis (letter). Clin Exp Rheumatol 9: 205-212.
57. Fiebich BL, Heinrich M, Hiller KO, Kammerer N. 2001. Inhibition of TNF-α synthesis in LPS-stimulated primary human monocytes by Harpagophytum extract SteiHap 69. Phytomedicine 8: 8-30.
58. Fiebich BL, Chrubasik S. 2004. Effects of an ethanolic salix extract on the release of selected inflammatory mediators in vitro. Phytomedicine 11: 135-138.
59. Flynn DL, Rafferty MF, Boctor AM. 1986. Inhibition of human neutrophil 5-lipoxygenase activity by gingerdione, shogaol, capsaicin and related pungent compounds. Prostoglandins Leukotrienes Med 24: 195-198.
60. Frerick H, Biller A, Schmidt U. 2001. A treatment schedule for coxarthrosis: A double-blind study with Devil's claw [Stufenschema bei coxarthrose: Doppelblindstudie mit Teufelskralle]. Kassenarzt 5: 34-41.
61. Frondoza CG, Sohrabi A, Polotsky A, Phan PV, Hungerford DS, Lindmark L. 2004. An in vitro screening assay for inhibitors of proinflammatory mediators in herbal extracts using human synoviocyte cultures. In Vitro Cellular. Developmental Biol - Animal 40: 95-101. (Pubitemid 39096224)
62. Gabay O, Gosset M, Levy A, Salvat C, Sanchez C, Pigenet A, Sautet A, Jacques C, Berenbaum F. 2008. Stress-induced signaling pathways in hyalin chondrocytes: Inhibition by avocado-soybean unsaponifiables (ASU). Osteoarthritis Cartilage 16: 373-384. (Pubitemid 351309176)
63. Gabriel SE, Jaakkimainen L, Bombardier C. 1991. Risk for serious gastrointestinal complications related to use of nonsteroidal anti-inflammatory drugs. A meta-analysis. Ann Int Med 115: 787-796.
64. Gayathri B, Manjula N, Vinaykumar KS, Lakshmi BS, Balakrishnan A. 2007. Pure compound from Boswellia serrata extract exhibits anti-inflammatory property in human PBMCs and mouse macrophages through inhibition of TNFα, IL-1β, NO and MAP kinases. Int Immunopharmacol 7: 473-482. (Pubitemid 46275555)
65. Glaser T, Winter S, Groscurth P, Safayhi H, Sailer ER, Ammon HP, Schabet M, Weller M. 1999. Boswellic acids and malignant glioma: Induction of apoptosis but no modulation of drug sensitivity. Br J Cancer 80: 756-765. (Pubitemid 29209838)
66. Glinko A. 1998. Pharmacological properties of a standardized extract from willow bark (Cortex salicis). Thesis: Pomeranian Academy of Medicine, Poland.
67. Goncalves C, Dinis T, Batista MT. 2005. Antioxidant properties of proanthocyanidins of Uncaria tomentosa bark decoction: A mechanism for anti-inflammatory activity. Phytochemistry 66: 89-98. (Pubitemid 40092730)
68. Grube B, Grunwald J, Krug L, Staiger C. 2007. Efficacy of a comfrey root (Symphyti offic. radix) extract ointment in the treatment of patients with painful osteoarthritis of the knee: Results of a double-blind, randomized, bicenter, placebo-controlled trial. Phytomedicine 14: 2-10. (Pubitemid 44960807)
69. Gundermann KJ. 2001. Clinical expert report. Darmstadt, Germany: Steigerwald.
70. Günther M, Laufer S, Schmidt PC. 2006. High anti-inflammatory activity of harpagoside-enriched extracts obtained from solvent-modified super- and subcritical carbon dioxide extractions of the roots of Harpagophytum procumbens. Phytochem Anal 17: 1-7. (Pubitemid 43141391)
71. Gürbüz I, Ustün O, Yesilada E, Sezik E, Kutsal O. 2003. Anti-ulcerogenic activity of some plants used as folk remedy in Turkey. J Ethnopharmacol 88: 93-97. (Pubitemid 36945355)
72. Hadzhiyski H, Lindhorst E, Raif W, Torda T, Chrubasik S. 2006. Impact of Harpagophytum procumbens on the urinary pyridinoline deoxypyridinoline ratio in experimental osteoarthritis [Abstract]. Focus Altern Complement Ther 11: 13.
73. Harput US, Saracoglu I, Ogihara Y. 2005. Stimulation of lymphocyte proliferation and inhibition of nitric oxide production by aqueous Urtica dioica extract. Phytotherapy Res 19: 346-348. (Pubitemid 41098131)
74. Hartwich A, Germann I, Kelber O, Muller J, Weizer D, Heinle H. 2006. Das pflanzliche Rheumapräparat STW 1 hat antioxidative Effekte. Zeitschr Rheumatol 65 (Suppl 1): 528.
75. Henrotin YE, Labasse AH, Jaspar JM, De Groote DD, Zheng SX, Guillou GB, Reginster JY. 1998. Effects of three avocado/soybean unsaponifiable mixtures on metalloproteinases, cytokines and prostaglandin E2 production by human articular chondrocytes. Clin Rheumatol 17: 31-39.
76. Henrotin YE, Sanchez C, Deberg MA, Piccardi N, Guillou GB, Msika P, Reginster JY. 2003. Avocado/soybean unsaponifiables increase aggrecan synthesis and reduce catabolic and proinflammatory mediator production by human osteoarthritic chondrocytes. J Rheumatol 30: 1825-1834. (Pubitemid 36962462)
77. Henrotin YE, Deberg MA, Crielaard JM, Piccardi N, Msika P, Sanchez C. 2006. Avocado/soybean unsaponifiables prevent the inhibitory effect of osteoarthritic subchondral osteoblasts on aggrecan and type II collagen synthesis by chondrocytes. J Rheumatol 33: 1668-1678. (Pubitemid 44168845)
78. Herman C, Allen P, Hunt WC, Prasad A, Brady TJ. 2004. Use of complementary therapies among primary care clinic patients with arthritis. Prev Chron Dis 1: 1-15.
79. Higgins JPT, Green S. 2008. Cochrane Handbook for Systematic Reviews of Interventions Version. Wiley-Blackwell: Chichester, UK.
80. Huang TH, Tran VH, Duke RK, Tan S, Chrubasik S, Roufogalis BD, Duke CC. 2006. Harpagoside suppresses lipopolysaccharide-induced iNOS and COX-2 expression through inhibition of NF-kB activation. J Ethnopharmacol 104: 149-155. (Pubitemid 43234097)
81. Huber B. 1991. Therapy of degenerative rheumatic diseases: Use of analgesic medication with Phytodolor N [Therapie degenerativer rheumatischer Erkrankungen: Bedarf an zusätzlicher analgetischer Medikation unter Phytodolor N]. Fortschr Med 109: 248-250.
82. ICH. 2004. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. Synopsis of ICH guidelines and topics. Author: Geneva, Switzerland.
83. Jäger AK, Eldeen IM, van Staden J. 2007. COX-1 and -2 activity of rose hip. Phytotherapy Res 21: 1251-1252.
84. Jung YB, Roh KJ, Jung JA, Jung K, Yoo H, Cho YB, Kwak WJ, Kim DK, Kim KH, Han CK. 2001. Effect of SKI306X, a new herbal anti-arthritic agent, in patients with osteoarthritis if the knee: A double-blind placebo controlled study. Am J Chinese Med 29: 485-491. (Pubitemid 33771639)
85. Jung YB, Seong SC, Lee MC, Shin YU, Kim DH, Kim JM, Jung YK, Ahn JH, Seo JG, Park YS, Lee CS, Roh KJ, Han CK, Cho YB, Chang DY, Kwak WJ, Jung KO, Park BJ. 2004. A four-week randomized, double-blind trial of the efficacy and safety of SKI306X: A herbal anti-arthritic agent versus diclofenac in osteoarthritis of the knee. Am J Chinese Med 32: 291-301. (Pubitemid 39011022)
86. Jürgensen S, Dalbo S, Angers P, Santos AR, Ribeiro-do-Valle RM. 2005. Involvement of 5-HT2 receptors in the antinociceptive effect of Uncaria tomentosa. Pharmacol Biochem Behav 81: 466-477. (Pubitemid 40966792)
87. Kahkonen MP, Hopia AI, Vuorela HJ, Rauha JP, Pihlaja K, Kujala TS, Heinonen M. 1999. Antioxidant activity of plant extracts containing phenolic compounds. J Agric Food Chem 47: 3954-3962. (Pubitemid 29506183)
88. Kanter M, Coskun O, Budancamanak M. 2005. Hepatoprotective effects of Nigella sativa L and Urtica dioica L on lipid peroxidation, antioxidant enzyme systems and liver enzymes in carbon tetrachloride-treated rats. World J Gastroenterol 11: 6684-6688. (Pubitemid 43072712)
89. Kaszkin M, Beck KF, Koch E, Erdelmeier C, Kusch S, Pfeilschifter J, Loew D. 2004. Downregulation of iNOS expression in rat mesangial cells by special extracts of Harpagophytum procumbens derives from harpagoside-dependent and independent effects. Phytomedicine 11: 585-595. (Pubitemid 40007740)
90. Khajuria A, Gupta A, Suden P, Singh S, Malik F, Singh J, Gupta BD, Suri KA, Srinivas VK, Ella K, Qazi GN. 2008. Immunomodulatory activity of biopolymeric fraction BOS 2000 from Boswellia serrata. Phytother Res 22: 340-348.
91. Khayyal MT, El-Ghazaly MA, Abdallah DM, Okpanyi SN, Kelber O, Weizer D. 2005. Mechanisms involved in the antiinflammatory effect of a standardized willow bark extract. Arzneimittel-Forsch/Drug Res 55: 677-687. (Pubitemid 41756051)
92. Kim OK, Murakami A, Takahashi D, Nakamura Y, Torikai K, Kim HW, Ohigashi H. 2000. An avocado constituent, persenone A, suppresses expression of inducible forms of nitric oxide synthase and cyclooxygenase in macrophages, and hydrogen peroxide generation in mouse skin. Biosci Biotech Biochem 64: 2504-2507.
93. Kim SO, Chun KS, Kundu JK, Surh YJ. 2004. Inhibitory effects of [6]-gingerol on PMA-induced COX-2 expression and activation of NF-kappaB and p38 MAPK in mouse skin. Biofactors 21: 27-31.
94. Kim JH, Ryu KH, Jung KW, Han CK, Kwak WJ, Cho YB. 2005. Effects of SKI306X on arachidonate metabolism and other inflammatory mediators. Bio Pharm Bull 28: 1615-1620.
95. Kimmatkar N, Thawani V, Hingorani L, Khiyani R. 2003. Efficacy and toerability of Boswellia serrata extract in treatment of osteoarthritis of knee - A randomized double blind placebo controlled trial. Phytomedicine 10: 3-7. (Pubitemid 36262200)
96. Kiuchi F, Iwakami S, Shibuya M, Hanaoka F, Sankawa U. 1992. Inhibition of prostaglandin and leukotriene biosynthesis by gingerols and diarylheptanoids. Chem Pharm Bull 40: 387-391.
97. Klaas CA, Wagner G, Laufer S, Sosa S, Della Loggia R, Bomme U, Pahl HL, Merfort I. 2002. Studies on the antiinflammatory activity of phytopharmaceuticals prepared from arnica flowers. Planta Med 68: 385-391. (Pubitemid 34606678)
98. Klingelhöfer S, Obertreis B, Quast S, Behnke B. 1999. Antirheumatic effect of IDS 23, a stinging nettle leaf extract, on in vitro expression of T helper cytokines. J Rheumatol 26: 2517-2522.
99. Krivoy N, Pavlotzky E, Chrubasik S, Eizenberg E, Brooks G. 2001. Effect of Salicis cortex extract on human platelet aggregation. Planta Med 67: 209-213. (Pubitemid 32304188)
100. Kundu JK, Mossanda KS, Na HK, Surh YJ. 2005. Inhibitory effects of the extracts of Sutherlandia frutescens (L.) R. Br. and Harpagophytum procumbens DC. on phorbol ester-induced COX-2 expression in mouse skin: AP-1 and CREB as potential upstream targets. Cancer Lett 281: 21-31.
101. Kuo PC, Damu AG, Cherng CY, Jeng JF, Teng CM, Lee EJ, Wu TS. 2005. Isolation of a natural antioxidant, dehydrozingerone from Zingiber officinale and synthesis of its analogues for recognition of effective antioxidant and antityrosinase agents. Arch Pharmacol Res 28: 518-528.
102. Kuppsamy UR, Khoo HE, Das NP. 1990. Structure-activity studies of flavonoids as inhibitors of hyaluronidase. Biochem Pharmacol 140: 397-401.
103. Kut C, Assoumou A, Dridi M, Bonnefoix M, Gogly B, Pellat B, Guillou GB, Godeau G. 1998. Morphometric analysis of human gingival elastic fibres degradation by human leukocyte elastase protective effect of avocado and soybean unsaponifiables (ASU). Pathol Biol 46: 571-576. (Pubitemid 28509088)
104. Kut-Lasserre C, Miller CC, Ejeil AL, Gogly B, Dridi M, Piccardi N, Guillou B, Pellat B, Godeau G. 2001. Effect of avocado and soybean unsaponifiables on gelatinase A (MMP-2), stromelysin 1 (MMP-3), and tissue inhibitors of matrix metalloproteinase (TIMP- 1 and TIMP-2) secretion by human fibroblasts in culture. J Periodont 72: 1685-1694. (Pubitemid 34092734)
105. Lantz RC, Chen GJ, Sarihan M, Sólyom AM, Jolad SD, Timmermann BN. 2007. The effect of extracts from ginger rhizome on inflammatory mediator production. Phytomedicine 14: 123-128. (Pubitemid 46136942)
106. Leban D, Chantre P, Foumie B. 2000. Harpogophytum procumbens in the treatment of knee and hip osteoarthritis: Four-month results of a prospective, multicenter, double-blind trial versus diacerhein. Joint Bone Spine 67: 462-467. (Pubitemid 30950689)
107. Lequesne M, Maheu E, Cadet C, Dreizer RL. 2002. Structural effect of avocado/soyabean unsaponifiables on joint space loss in osteoarthritis of the hip. Arthritis Care Res 47: 50-58. (Pubitemid 34137344)
108. Little CV, Parsons T, Logan S. 2000. Herbal therapy for treating osteoarthritis. Cochrane Database of Systematic Reviews, ISSUE 4. Art. No.: CD002947 DOI: 10.1002/14651858.CD002947.
109. Loew D, Schuster O, Mollerfeld J. 1996. Stability and biopharmaceutical quality. A postulate for bioavailability and effectiveness of Harpagophytum procumbens [Stabilitat und biopharmazeutische Qualitat. Voraussetzung für Bioverfügbarkeit und Wirksamkeit von Harpagophytum procumbens]. In Phytopharmaka II. Forschung und klinische Anwendung, Loew D, Rietcrock N (eds). Steinkopf-Verlag: Darmstadt; 83-93.
110. Loew D, Mollerfeld J, Schrodter A, Puttkammer S, Kaszkin M. 2001. Investigations on the pharmacokinetic properties of Harpagophytum extracts and their effects on eicosanoid biosynthesis in vitro and ex vivo. Clin Pharmacol Ther 69: 356-364. (Pubitemid 32477077)
111. Lyss G, Schmidt TJ, Merfort I, Pahl HL. 1997. Helenalin, an antiinflammatory sesquiterpene lactone from Arnica, selectively inhibits transcription factor NF-kappaB. Biol Chem 378: 951-961. (Pubitemid 27438016)
112. Maheu E, Mazieres B, Valat J-P, Loyau G, Le Loet X, Bourgeois P, Grouin JM, Rozenberg S. 1998. Symptomatic efficacy of avocado/soybean unsaponifiables in the treatment of osteoarthritis of the knee and hip. Arthritis Rheum 41: 81-91.
113. Mahomed IM, Ojewole JAO. 2006. Oxytocin-like effect of Harpagophytum procumbens DC (pedaliaceae) secondary root aqueous extraction on rat isolated uterus. Africa J Trad Complement Alternat Med 3: 82-89.
114. Mauviel A, Loyau G, Pujol JP. 1991. Effect of unsaponifiable extracts of avocado and soybean (Piascledine) on the collagenolytic action of cultures of human rheumatoid synoviocytes and rabbit articular chondrocytes treated with interleukin-1 [Effect des insaponifiables d'avocat/soja (Piascledine) sur l'activite collagenolytique de cultures des synovocytes rhumatoides humains et de chondrocytes articulaires de lapin traites par l'interleukine-1]. Rev Rhum Mal Osteoartic 58: 241-245.
115. Mazieres B, Tempesta C, Tiechard M, Vaguier G. 1993. Pathologic and biochemical effects of a lipidic avocado and soya extract on an experimental post-contusive model of OA [Abstract]. Osteoarthritis Cartilage 1: 46.
116. McCarthy GM, McCarthy DJ. 1992. Effect of topical capsaicin in the therapy of painful osteoarthritis of the hands. J Rheumatology 19: 604-607.
117. McCleane G. 2000. The analgesic efficacy of topical capsaicin is enhanced by glyceryl trinitrate in painful osteoarthritis: A randomized, double blind, placebo controlled study. Eur J Pain 4: 355-360. (Pubitemid 32104310)
118. Melzig MF, Löser B, Lobitz GO, Tamayo-Castillo G, Merfort I. 1999. Inhibition of granulocyte elastase activity by caffeic acid derivatives. Pharmazie 54: 712. (Pubitemid 29444861)
119. Meyer B, Schneider W, Elstner EF. 1995. Antioxidative properties of alcoholic extracts from Fraxinus excelsior, Populus tremula and Solidago virgaurea. Arzneimittel-Forsch/Drug Res 45: 174-176.
120. Miller MJ, Ahmed S, Bobrowski P, Haqqi TM. 2006. The chrondoprotective actions of a natural product are associated with the activation of IGF-1 production by human chondrocytes despite the presence of IL-1β. BMC Complement Altern Med 7: 6-13.
121. Mills SY, Jacoby RK, Chacksfield M, Willoughby M. 1996. Effect of a proprietary herbal medicine on the relief of chronic arthritic pain: A double-blind study. Br J Rheumatol 35: 874-878. (Pubitemid 126433933)
122. Moher D, Schulz KF, Altman DG. 2001. The CONSORT statement: Revised recommendations for improving the quality of reports of parallel-group randomized trials. Ann Int Med 134: 657-662. (Pubitemid 32322244)
123. Na HK, Mossanda KS, Lee JY, Surh YJ. 2004. Inhibition of phorbol ester-induced COX-2 expression by some edible African plants. Biofactors 21: 149-153.
124. Nolano M, Simone DA, Wendelschafer-Crabb G, Johnson T, Hazen E, Kennedy WR. 1999. Topical capsaicin in humans: Parallel loss of epidermal nerve fibers and pain sensation. Pain 81: 135-145. (Pubitemid 29199909)
125. Nurtjahja-Tjendraputra E, Ammit AJ, Roufogalis BD, Tran VH, Duke CC. 2003. Effective anti-platelet and COX-1 enzyme inhibitors from pungent constituents of ginger. Thrombosis Res 111: 259-265. (Pubitemid 38021945)
126. Obertreis B, Giller K, Teucher T, Behnke B, Schmitz H. 1996a. Anti-inflammatory effect of Urtica dioica folia extract in comparison to caffeic malic acid [Antiphlogistische Effekte von Extractum Urticae dioicae foliorum im Vergleich zu Kaffeoyläpfelsäure]. Arzneimittel-Forsch/Drug Res 46: 52-56.
127. Obertreis B, Ruttkowski T, Teucher T, Behnke B, Schmitz H. 1996b. Ex-vivo in-vitro inhibition of lipopolysaccharide stimulated tumor necrosis factor-alpha and interleukin-1 beta secretion in human whole blood by extractum Urticae dioicae foliorum [Ex-vivo-in-vitro-Hemmung der Lipopolysaccharid- stimulierten Tumor-Nekrose-Faktor-α und Interleukin-1β-Sekretion in humanem Vollblut durch Extractum Urticae dioicae foliorum]. Arzneimittel-Forsch/ Drug Res 46: 389-394.
128. Ofman JJ, MacLean CH, Straus WL, Morton SC, Berger ML, Roth EA, Shekelle P. 2002. A metaanalysis of severe upper gastrointestinal complications of nonsteroidal antiinflammatory drugs. J Rheumatology 29: 804-812. (Pubitemid 34303877)
129. Ofman JJ, Maclean CH, Straus WL, Morton SC, Berger ML, Roth EA, Shekelle PG. 2003. Meta-analysis of dyspepsia and nonsteroidal antiinflammatory drugs. Arthritis Rheum 49: 508-518. (Pubitemid 36992191)
130. Ozen T, Korkmaz H. 2003. Modulatory effect of Urtica dioica L. (Urticaceae) leaf extract on biotransformation enzyme systems, antioxidant enzymes, lactate dehydrogenase and lipid peroxidation in mice. Phytomedicine 10: 405-415. (Pubitemid 36745164)
131. Pilarski R, Zielinski H, Ciesiolka D, Gulewicz K. 2006. Antioxidant activity of ethanolic and aqueous extracts of Uncaria tomentosa (Willd.) DC. J Ethnopharmacol 104: 18-23. (Pubitemid 43239472)
132. Piscoya J, Rodriguez Z, Bustamante SA, Okuhama NN, Miller MJS, Sandoval M. 2001. Efficacy and safety of freeze-dried cat's claw in osteoarthritis of the knee: Mechanism of action of the species Uncaria guianensis. Inflammation Res 50: 442-448. (Pubitemid 32889443)
133. Poeckel D, Tausch L, Kather N, Jauch J, Werz O. 2006. Boswellic acids stimulate arachidonic acid release and 12-lipoxygenase activity in human platelets independent of Ca2+ and differentially interact with platelet-type 12-lipoxygenase. Mol Pharmacology 70: 1071-1078. (Pubitemid 44268464)
134. Randall C, Randall H, Dobbs F, Hutton C, Sanders H. 2000. Randomized controlled trial of nettle sting for treatment of base-of-thumb pain. J. Royal Sci Med 93: 305-309. (Pubitemid 30392049)
135. Rein E, Kharazami A, Winther K. 2004. A herbal remedy, Hyben Vital (stand. powder of a subspecies of Rosa canina fruits), reduces pain and improves general wellbeing in patients with osteoarthritis - a double-blind, placebo-controlled, randomized trial. Phytomedicine 11: 383-391. (Pubitemid 38980518)
136. Rennert B, Melzig MF. 2002. Free fatty acids inhibit the activity of Clostridium histolyticum collagenase and human neutrophil elastase. Planta Med 68: 767-769. (Pubitemid 35177617)
137. Riehemann K, Behnke B, Schulze-Osthoff K. 1999. Plant extracts from stinging nettle (Urtica dioica), an antirheumatic remedy, inhibit the proinflammatory transcription factor NF-kappaB. FEBS Lett 442: 89-94. (Pubitemid 29065385)
138. Rohnert U, Schneider W, Elster EF. 1998a. Superoxid-dependent and -independent nitrite formation from hydroxylamine: Inhibition by plant extracts. Zeitschr Naturforsch 53: 241-249. (Pubitemid 28214233)
139. Rohnert U, Koske D, Schneider W, Elstner E. 1998b. Inhibition by Salix extracts and Phytodolor of copper-catalyzed oxidative destructions. Zeitschr Naturforsch 53: 233-240. (Pubitemid 28214232)
140. Roy S, Khanna S, Shah H, Rink C, Phillips C, Preuss H, Subbaraju GV, Trimurtulu G, Krishnaraju AV, Bagchi M, Bagchi D, Sen CK. 2005. Human genome screen to identify the genetic basis of the anti-inflammatory effects of Boswellia in microvascular endothelial cells. DNA Cell Biol 24: 244-255. (Pubitemid 40490263)
141. Roy S, Khanna S, Krishnaraju AV, Subbaraju GV, Yasmin T, Bagchi D, Sen CK. 2006. Regulation of vascular responses to inflammation: inducible matrix metalloproteinase-3 expression in human microvascular endothelial cells is sensitive to anti-inflammatory Boswellia. Antioxidants Redox Signaling 8: 653-660. (Pubitemid 43741333)
142. Safayhi H, Rall B, Sailer ER, Ammon HP. 1997. Inhibition by boswellic acids of human leukocyte elastase. J Pharmacol Exp Ther 281: 460-463. (Pubitemid 27203102)
143. Sandoval M, Charbonnet RM, Okuhama NN, Roberts J, Krenova Z, Trentacosti AM, Miller MJ. 2000. Cat's claw inhibits TNFα production and scavenges free radicals: Role in cytoprotection. Free Radic Biol Med 29: 71-78. (Pubitemid 30658139)
144. Sandoval M, Okuhama NN, Zhang XJ, Condezo LA, Lao J, Angeles FM, Musah RA, Bobrowski P, Miller MJ. 2002. Antiinflammatory and antioxidant activities of cat's claw (Uncaria tomentosa and Uncaria guianensis) are independent of their alkaloid content. Phytomedicine 9: 325-337. (Pubitemid 34712504)
145. Sangha O. 2000. Epidemiology of rheumatic diseases. Rheumatology 39 (Supp 2): 3-12.
146. Schadler W. 1988. Phytodolor for the treatment of activated arthrosis. Rheuma 8: 288-290.
147. Schaser J, Bonaterra GA, Kelber O, Weizer D, Kinscherf R, Metz J. 2006. Untersuchung antiinflammatorischer Effekte des Phytopharmakons Phytodolor und seiner Einzelkomponenten in einem Monozyten-Testmodell. Perfusion 19: 76-77.
148. Schmelz H, Hämmerle HD, Springorum HW. 1997. Analgesic effect of a Devils claw extract in various chronic degen erative joint diseases [Analgetische Wirkung eines Teu felskrallenwurzel-Extraktes bei verschiedenen chronisch-degenerativen Gelenkerkrankungen]. In Rheumatherapie mit Phytopharmaka, Chrubasik S, Wink M (eds). Hippokrates Verlag: Stuttgart; 86-89.
149. Schmid B, Ludtke R, Selbmann HK, Kotter I, Tschirdewahn B, Schaffner W. 2000. Efficacy and tolerability of a standardized willow bark extract in patients with osteoarthritis: Randomized placebo-controlled double blind clinical trial [Wirksamkeit und vertraglichkeit eines standardisierten Weidenrindenextraktes bei Arthrose-Patienten: Randomisierte, placebo-kontrollierte Doppelblindstudie]. Zschr Rheumatologie 59:1-7.
150. Schnitzer T, Morton C, Coker S. 1994. Topical capsaicin therapy for osteoarthritis pain: Achieving a maintenance regimen. Seminars in Arthritis Rheum 23 (Supp 3): 34-40. (Pubitemid 24209633)
151. Schulze-Tanzil G, de Souza P, Behnke B, Klingelhoefer S, Scheid A, Shakibaei M. 2002. Effects of the antirheumatic remedy Hox alpha-a new stinging nettle leaf extract-on matrix metalloproteinases in human chondrocytes in vitro. Histology Histopath 17: 477-485. (Pubitemid 34411207)
152. Schünemann HJ, Oxman AD, Higgins JPT, Vist GE, Glasziou P, Guyatt GH. 2008a. Chapter 11: Presenting results and 'Summary of findings tables'. In Cochrane Handbook for Systematic Reviews of Interventions, Higgins JPT, Green S (eds). Wiley-Blackwell: Chichester, UK.
153. Schünemann HJ, Oxman AD, Vist GE, Higgins JPT, Deeks JJ, Glasziou P, Guyatt GH. 2008b. Chapter 12: Interpreting results and drawing conclusions. In Cochrane Handbook for Systematic Reviews of Interventions, Higgins JPT, Green S (eds). Wiley-Blackwell: Chichester, UK.
154. Siedle B, Gustavsson L, Johansson S, Murillo R, Castro V, Bohlin L, Merfort I. 2003. The effect of sesquiterpene lactones on the release of human neutrophil elastase. Biochem Pharmacol 65: 897-903. (Pubitemid 36293705)
155. Siemoneit U, Hofmann B, Kather N, Lamkemeyer T, Madlung J, Franke L, Schneider G, Jauch J, Poeckel D, Werz O. 2008. Identification and functional analysis of cyclooxygenase-1 as a molecular target of boswellic acids. Biochem Pharmacol 5: 503-513. (Pubitemid 350298477)
156. Smalley WE, Griffin MR, Fought RL, Ray WA. 1996. Excess costs from gastrointestinal dizease associated with nonsteroidal anti-inflammatory drugs. J General Internal Med 11: 461-469. (Pubitemid 26299146)
157. Sporer F, Chrubasik S. 1999. Preparations from Devil's claw (Harpagophytum procumbens) [Präparate aus der Teufelskralle (Harpagophytum procumbens)]. Zschr Phytotherapie 20: 235-236. (Pubitemid 30107992)
158. Stoové MA, Andersen MB. 2003. What are we looking at, and how big is it? Physical Therapy in Sport 4: 93-97. (Pubitemid 36764457)
159. Strehl E, Schneider W, Elstner EF. 1995. Inhibition of dihydrofolate reductase activity by alcoholic extacts from Fraxinus excelsior, Populus tremula and Solidago virgaurea. Arneimittel-Forsch/Drug Res 45: 172-173.
160. Takada Y, Ichikawa H, Badmaev V, Aggarwal BB. 2006. Acetyl-11-keto-beta- boswellic acid potentiates apoptosis, inhibits invasion, and abolishes osteoclastogenesis by suppressing NF-kappa B and NF-kappa B-regulated gene expression. J Immunology 76: 3127-3140. (Pubitemid 43306975)
161. Teekachunhatean S, Kunanusom P, Rojanasthien N, Sanan panich K, Pojchamarnwitputh S, Lheiochaiphunt S, Pruksakorn S. 2004. Chinese herbal recipe versus diclofenac in sym ptomatic treatment of osteoarthritis of the knee: A randomized controlled trial. BMC Comlementary Alternative Med 4: 19.
162. Teucher T, Obertreis B, Ruttkowski T, Schmitz H. 1996. Cytokine secretion in whole blood of healthy subjects following oral administration of Urtica dioica L. plant extract [Zytokin-Sekretion im Vollblut gesunder Probanden nach oraler Einnahme eines Urtica dioica L.-Blattextraktes]. Arzneimittel-Forsch/Drug Res 46: 906-910.
163. Tjendraputra E, Tran VH, Liu-Brennan D, Roufogalis BD, Duke CC. 2001. Effect of ginger constituents and synthetic analogues on cyclooxygenase-2 enzyme in intact cells. Bioorganic Chem 29: 156-163. (Pubitemid 34226237)
164. Tornhamre S, Schmidt TJ, Näsman-Glaser B, Ericsson I, Lindgren JA. 2001. Inhibitory effects of helenalin and related compounds on 5-lipoxygenase and leukotriene C4 synthase in human blood cells. Biochem Pharmacol 62: 903-911. (Pubitemid 32816976)
165. Tsukahara K, Nakagawa H, Moriwaki S, Takema Y, Fujimura T, Imokawa G. 2006. Inhibition of ultraviolet-B-induced wrinkle formation by an elastase-inhibiting herbal extract: implication for the mechanism underlying elastase-associated wrinkles. Int J Dermatol 45: 460-468.
166. von Kruedener S, Schneider W, Elstner EF. 1996. Effects of extracts from Populus tremula L., Solidago virgaurea L. and Fraxinus excelsior L. on various myeloperoxidase systems. Arzneimittelforsch/Drug Res 46: 809-814. (Pubitemid 26275640)
167. Wang CC, Chen LG, Lee LT, Yang LL. 2003. Effects of 6-gingerol, an antioxidant from ginger, on inducing apoptosis in human leukemic HL-60 cells. In Vivo 17: 641-645.
168. Warholm O, Skaar S, Hedman E, Molmen HM, Eik L. 2003. The effects of a standardized herbal remedy made from a subtype of Rosa canina in patients with osteoarthritis: A double-blind, randomized, placebo-controlled clinical trial. Current Therapeutic Res 64: 21-31. (Pubitemid 36308442)
169. Wenzig EM, Widowitz U, Chrubasik S, Bucar F, Knauder E, Bauer R. 2007. Phytochemical and in vitro pharmacological comparison of two rose hip preparations. Phytomedicine 15: 826-835.
170. Whitehouse LW, Znamirowska M, Paul CJ. 1983. Devil's Claw (Harpagophytum procumbens): no evidence for antiinflammatory activity in the treatment of arthritic dizease. Can Med Assoc J 129: 249-251.
171. Widrig R, Suter A, Saller R, Melzer J. 2007. Choosing between NSAID and Arnica for topical treatment of hand osteoarthritis in a randomized, double-blind study. Rheumatol Int 27: 585-591. (Pubitemid 46411900)
172. Wigler I, Grotto I, Caspi D, Yaron M. 2003. The effects of Zintona EC (a ginger extract) on symptomatic gonarthritis. Osteoarthritis Cartilage 11: 783-789. (Pubitemid 37407594)
173. Wildfeuer A, Neu IS, Safayhi H, Metzger G, Wehrmann M, Vogel U, Ammon HP. 1998. Effects of boswellic acids extracted from a herbal medicine on the biosynthesis of leukotrienes and the course of experimental autoimmune encephalomyelitis. Arzneimittelforsch/Drug Res 48: 668-674. (Pubitemid 28308193)
174. Winther K, Apel K, Thamsborg G. 2005. A powder made from seeds and shells of a rose-hip subspecies (Rosa canina) reduces symptoms of knee and hip osteoarthritis: A randomized, double-blind, placebo-controlled clinical trial. Scand J Rheumatol 34: 302-308. (Pubitemid 41215665)
175. Winther K, Kharazmi A, Rein E. 2004. A powder made from a subspecies of rosehip (Rosa canina) reduces WOMAC symptoms scores as well as cholesterol levels in patients suffering from osteoarthritis. Osteoarthritis Cartilage 13 (Supp A): S93.
176. Wu H, Ye DJ, Zhao YZ, Wang SL. 1993. Effect of different preprations of ginger on blood coagulation time in mice. Zhongguo Zhon Yao Za Zhi 18: 147-149.
177. Wurm G, Baumann J, Geres U. 1982. Method for inhibiting cyclooxygenase and inflammation using cherry bioflavonoids [Beeinflussung des Arachidonsäurestoffwechsels durch Flavonoide]. Dtsch Apotheker Ztg 122: 2062-2068.
178. Zhou Y, Xu R. 1992. Antioxidative effect of Chinese drugs. Chung Kuo Chung Yao Tsa Chih 17: 368-369, 373.